1. Home
  2. BRZE vs GPCR Comparison

BRZE vs GPCR Comparison

Compare BRZE & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braze Inc.

BRZE

Braze Inc.

HOLD

Current Price

$23.98

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$49.34

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRZE
GPCR
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
BRZE
GPCR
Price
$23.98
$49.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
26
12
Target Price
$37.88
$103.17
AVG Volume (30 Days)
2.0M
660.5K
Earning Date
05-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$738,182,000.00
N/A
Revenue This Year
$22.69
N/A
Revenue Next Year
$16.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.40
N/A
52 Week Low
$15.26
$15.80
52 Week High
$37.33
$94.90

Technical Indicators

Market Signals
Indicator
BRZE
GPCR
Relative Strength Index (RSI) 53.24 50.96
Support Level $22.09 $43.76
Resistance Level $24.53 $57.15
Average True Range (ATR) 1.58 2.71
MACD -0.34 -0.57
Stochastic Oscillator 55.86 39.30

Price Performance

Historical Comparison
BRZE
GPCR

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates the majority of its revenue from the United States.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: